Further studies are required to understand the underlying reasons and whether it is patient preference, physician attitudes, payers, or some other factor driving the dosing patterns we observed as part of this descriptive study
In 2024, the FDA said that GLP-1 drugs were no longer in a shortage, which was expected to put an end to the compounding
Eli Lillys role in accessibility : Aimed at making treatments for obesity more accessible despite high costs and limited insurance coverage
Recalls & Warnings November 14, 2012 Maker of Vitamin C, Aloe and Sexual Enhancement Supplements Warned for Drug Claims and Misbranding On October 22, 2012, the FDA issued a warning letter to Health Breakthroughs International, LLC after a review of the company's product labels and website found the dietary supplements Amazing C, MPS-Gold 100 and Power Herbal Formula to be promoted as drugs
Never reuse needles or throw them loosely in the trash